-
February 27, 2013
Ablynx of Belgium says that it enjoyed a year of "strong operational and financial progress
Full story
-
February 14, 2013
PharmaTimes and healthcare network organisation Visions4Health have launched a special one-day speed dating event to bring together CCGs and NHS providers with qualified healthcare industry stakeholders.
Full story
-
January 10, 2013
AstraZeneca has been talking about the importance of expanding its network of collaborations at the JPMorgan healthcare conference in San Francisco, where it has scheduled 320 meetings
Full story
-
November 30, 2012
Partnering with pharma will make medicines optimisation a success
Full story
-
May 29, 2012
Lundbeck says its investigational Alzheimer's disease drug Lu AE58054 has met its primary endpoint in a mid-stage study
Full story
-
January 12, 2012
Access to capital, a burdensome and uncertain regulatory environment and lack of innovation and productivity in R&D are the biggest threats to US biomedical industry growth over the next five years, according to sector leaders.
Full story
-
October 11, 2011
In the face of ongoing economic pressure and risk aversion, the evolution of partnering in drug development "is leading to a re-evaluated approach to biotechnology", according to consultants Deloitte
Full story
-
August 23, 2011
The government has announced five-year funding of £800 million for early-stage health research - the UK's largest-ever investment in diagnosis, prevention and treatment.
Full story